Investor FAQ

Investor FAQs

Show all

We are eligible for trading on the NASDAQ.
The ticker symbol under which we trade is "ZIOP."
Ziopharm, Inc., our private company predecessor, commenced operations in January 2004.
Our operations are located in Houston, TX and Boston, MA.
Ziopharm Oncology's transfer agent is:

American Stock Transfer & Trust Company
6201 15th Avenue,
Brooklyn, New York 11219
Attn: Shareholder Services
1-877-248-6417 or 1-718-921-8317
Please contact our transfer agent (as above).
Contact our transfer agent (as above).
No. Ziopharm Oncology does not currently have a direct stock purchase plan and is not offering to sell shares of its stock to the public.
Please click here to see the members of Ziopharm’s board of directors. For more information concerning corporate governance and board committees please click here
Please click here to see the members of Ziopharm’s executive management team.
Please click here to see the members of ZIOPHARM’s medical advisory board.
Our fiscal year coincides with the calendar year. As a result, our fiscal year end is December 31st each year.
Please visit the events page under Investor Relations.
Please click here to be directed to the email alerts page.